Review in ACS chemical neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 9 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors at 3 institutions in 2 countries.
Juan M Rojas CabreraMedical Scientist Training Program, Mayo Clinic, Rochester, Minnesota 55902, United States.ORCID 0000-0001-8131-5546
Tyler S OesterleDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota 55902, United States.
Aaron E RusheenMedical Scientist Training Program, Mayo Clinic, Rochester, Minnesota 55902, United States.
Abhinav GoyalMedical Scientist Training Program, Mayo Clinic, Rochester, Minnesota 55902, United States.
Kristen M ScheitlerDepartment of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States.
Ian MandyburDepartment of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States.
Charles D BlahaDepartment of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States.
Kevin E BennetDepartment of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States.
Michael L HeienDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.ORCID 0000-0001-5164-9596
Dong Pyo JangDepartment of Biomedical Engineering, Hanyang University, Seoul 04763, South Korea.ORCID 0000-0002-2832-2576
Kendall H LeeDepartment of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States.
Yoonbae OhDepartment of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States.ORCID 0000-0003-1779-978X
Hojin ShinDepartment of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States.ORCID 0000-0001-6095-5122
Mayo Clinic · USHanyang University · KRUniversity of Arizona · US
Funding
NRSA Training CoreTL1TR002380 · NCATS · MAYO CLINIC ROCHESTER · PI Felicity T. B. Enders, ANTHONY John WINDEBANK · 2017 to 2026
$6.0M
Medical Scientist Traning Program at Mayo ClinicT32GM065841 · NIGMS · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H, SCHIMMENTI, LISA A · 2003 to 2022
$5.8M
MSTP at Mayo Clinic RochesterT32GM145408 · NIGMS · MAYO CLINIC ROCHESTER · PI SCOTT H KAUFMANN, LISA A SCHIMMENTI · 2023 to 2026
$4.7M
An Integrated Neurochemical/Electrophysiological Recording and Neuromodulation System for Basic and Clinical ResearchR42NS125895 · NINDS · WINCS INTERNATIONAL, LLC · PI Kevin Elliott Bennet, Kendall Lee · 2022 to 2026
$2.3M
Development of an innovative in vivo voltammetric technique for measurements of tonic serotonin concentrations in the mammalian brain.R01NS129549 · NINDS · MAYO CLINIC ROCHESTER · PI Kendall H. Lee, Yoonbae Oh · 2023 to 2026
$2.3M
Development of advanced voltammetric method for basal neurotransmitter level measurementR01NS112176 · NINDS · MAYO CLINIC ROCHESTER · PI LEE, KENDALL H., OH, YOONBAE · 2019 to 2022
$1.4M
Mechanism of CMPf Deep Brain Stimulation for Tourette SyndromeF31NS115202 · NINDS · MAYO CLINIC ROCHESTER · PI RUSHEEN, AARON ELLIOTT · 2020 to 2023
Serotonin (5-HT) is a monoamine neurotransmitter in the peripheral, enteric, and central nervous systems (CNS). Within the CNS, serotonin is principally involved in mood regulation and reward-seeking behaviors. It is a critical regulator in CNS pathologies such as major depressive disorder, addiction, and schizophrenia. Consequently,
Indexed as
Major Depressive DisorderSerotoninCentral Nervous SystemHumansNeurotransmitter AgentsProspective StudiesNeurotransmitter AgentsSerotoninaddictiondepressionelectrochemistryFSCAVFSCVMDDN-MCSWVopioidsschizophreniaSerotonin
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Techniques for Measurement of Serotonin: Implications in Neuropsychiatric Disorders and Advances in Absolute Value Recording Methods. · full record | OpenQuestion